Insulet
PODD
528 hedge funds and large institutions have $11.1B invested in Insulet in 2023 Q3 according to their latest regulatory filings, with 79 funds opening new positions, 203 increasing their positions, 190 reducing their positions, and 122 closing their positions.
7% more repeat investments, than reductions
Existing positions increased: 203 | Existing positions reduced: 190
2.98% less ownership
Funds ownership: 102.93% → 99.95% (-3%)
9% less funds holding
Funds holding: 578 → 528 (-50)
24% less call options, than puts
Call options by funds: $120M | Put options by funds: $158M
35% less first-time investments, than exits
New positions opened: 79 | Existing positions closed: 122
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
46% less capital invested
Capital invested by funds: $20.7B → $11.1B (-$9.54B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
+$616M |
| 2 |
DCP
D1 Capital Partners
New York
|
+$246M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$245M |
| 4 |
William Blair Investment Management
Chicago,
Illinois
|
+$97.2M |
| 5 |
Morgan Stanley
New York
|
+$74.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$519M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$502M |
| 3 |
JP Morgan Chase
New York
|
-$362M |
| 4 |
Capital World Investors
Los Angeles,
California
|
-$220M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$143M |
PODD Hedge Fund Activity: Q3 2023 in Review
528 of the 6,310 institutional investors tracked by Wall St. Rank reported a position in Insulet (PODD) for Q3 2023, worth a combined $11.1B — down 46% from $20.7B a quarter earlier.
Sellers outnumbered buyers: 122 funds closed out of PODD and 79 opened new positions — a net loss of 43 holders — while 190 trimmed existing stakes and 203 added.
The largest buyer was Capital Research Global Investors, adding an estimated $616M. The largest seller was Fidelity Investments, cutting an estimated $519M.
- 528 institutional investors held Insulet (PODD) as of Q3 2023, down from 578 in Q2 2023.
- Funds reported $11.1B of Insulet stock for Q3 2023, down 46% quarter-over-quarter.
- 79 funds opened new Insulet positions in Q3 2023 and 122 closed out, a net change of -43 holders.
- The largest Insulet buyer in Q3 2023 was Capital Research Global Investors, an estimated $616M added.
- The largest Insulet seller in Q3 2023 was Fidelity Investments, an estimated $519M sold.
Based on aggregated 13F filings for Q3 2023.